You just read:

Global Atopic Dermatitis Epidemiology and Patient-Based Market 2015-2024: Dupilumab is Expected to be the First Biologic Approved for Atopic Dermatitis

News provided by

Research and Markets

Aug 12, 2016, 09:10 ET